Three (3) cases of advanced Hepatocellular Carcinoma (HCC) treated successfully by Transcatheter Arterial Chemoembolization (TACE) using lipiodol and a fine-powder formulated cisplatin (DDPH)

Japanese Journal of Cancer and Chemotherapy

Volumn 36, Issue 3, 2009, Pages 479-483

  Kasai, Kazuhiro ^a   Kuroda, Hidekatsu ^b   Ushio, Akira ^b   Miyamoto, Yasuhiro ^b   Sawara, Kei ^b   Miyasaka, Aikio ^b   Takikawa, Yasuhiro ^b   Suzuki, Kazuyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Cisplatin; DDPH; Hepatocellular carcinoma; TACE

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; DECARBOXYPROTHROMBIN; DOXORUBICIN; IODINATED POPPYSEED OIL; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CASE REPORT; CHEMOEMBOLIZATION; CHRONIC HEPATITIS; DIABETES MELLITUS; DRUG FORMULATION; DRUG SUBSTITUTION; EMULSION; HUMAN; LIVER CELL CARCINOMA; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE CANCER; POWDER; PROGNOSIS; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME; TUMOR THROMBUS; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT;

EID: 79959856481     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ohtomo K, Furui S, Kokubo T, et al: Transcatheter arterial embolization (TAE) in treatment for hepatoma-analysis of three-year survivors. Radiat Med 3:176-180, 1985.
2. Shiina S, Teratani T, Obi S, et al: Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 62(Suppl 1):64-68, 2002. (Pubitemid 34702022)
3. Yamada R, Sato M, Kawabata M, et al: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397-401, 1983. (Pubitemid 13073577)
4. Kanematsu T, Furuta T, Takenaka K, et al: A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 10:98-102, 1989. (Pubitemid 19170010)
5. Takayasu K, Suzuki M, Uesaka K, et al: Hepatic artery, embolization for inoperable hepatocellular carcinoma; prognosis and risk factors. Cancer Chemother Pharmacol 23(Suppl):S123-125, 1989.
6. Shimamura Y, Gunvén P, Takenaka Y, et al: Combined peripheral and central chemoembolization of liver tumors. Experience with lipiodol-doxorubicin and gelatin sponge (L-TAE). Cancer 61:238-242, 1988.
7. Kawai S, Okamura J, Ogawa M, et al: Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma - a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). Cancer Chemother Pharmacol 31:S1-S6, 1992.
8. Takayasu K, Shima Y, Murayasu Y, et al: Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 163:345-351, 1987.
9. Uchiyama N, Kobayashi H, Nakajo M, et al: Treatment of lung cancer with bronchial artery infusion of cisplatin and intravenous sodium thiosulfate rescue. Acta Oncol 27:57-61, 1988.
10. Ono Y, Yoshimatsu T, Ashikaga R, et al: Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma. Am J Clin Oncol 23:564-568, 2000. (Pubitemid 32429101)
11. Kamada K, Nakanishi T, Kitamoto M, et al: Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion. J Vasc Interv Radiol 12:847-854, 2001. (Pubitemid 32642435)
12. Kasugai H, Kojima J, Tatsuta M, et al: Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 97:965-971, 1989.
13. Yamamoto K, Shimizu T and Narabayashi I: Intraarterial infusion chemotherapy with lipiodol-CDDP suspension for hepatocellular carcinoma. Cardiovasc Intervent Radiol 23:26-39, 2000. (Pubitemid 30182705)
14. Yoshikawa M, Ono N, Yodono H, et al: Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma. Hepatol Res 38:474-483, 2008. (Pubitemid 351593948)
15. Doroshow JH, Locker GY and Myers CE: Experimental animal models of adriamycin cardiotoxicity. Cancer Treat Rep 63:855-860, 1979. (Pubitemid 9248188)
16. Olson HM and Capen CC: Subacute cardiotoxicity of adriamycin in rat: biochemical and ultrastructural investigations. Lab Invest 37:386-394, 1977. (Pubitemid 8205406)